Ohio State University, Hilliard
DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro, Springboro
Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07415044

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Dayton Gastroenterology, LLC, Dayton

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07186101

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

University Hospitals Cleveland Medical Center /ID# 271831, Cleveland

Nagre-recruitPhase 3

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07071519

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Cleveland Clinic Foundation, Cleveland

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07513181

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

University of Cincinnati, Cincinnati
Ohio Gastroenterology group, Inc., Columbus
Gastro Intestinal Research Institute of Northern Ohio, LLC., Westlake

Nagre-recruitPhase 4

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
OSU Wexner Medical Center - Site Number: 8400077, Columbus
North Shore Gastroenterology Research - Site Number: 8400130, Westlake

Nagre-recruitPhase 3

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07185009

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Gastro Health Research - Cincinnati, Cincinnati
DSI Research Northridge LLC, Dayton
Gastro Health Research - Liberty Township, Liberty Township
at 3 pa

Nagre-recruitPhase 4

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06581328

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Great Lakes Gastroenterology Research, LLC, Mentor

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Gastroenterology & Hepatology Specialists, Inc. - Site Number: 8400139, Canton
Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
OSU Wexner Medical Center - Site Number: 8400077, Columbus
at 4 pa

Nagre-recruitPhase 3

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07184996

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

University of Cincinnati, Cincinnati

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07237516

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

GCGA Physicians, LLC dba / Gastro Health Research, Cincinnati
NexGen Research, Lima

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT06598943

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

University of Cincinnati College of Medicine, Cincinnati
Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

University Hospitals Cleveland Medical Center Rainbow Babies & Children's Hospital, Cleveland
University Hospitals Cleveland Medical Center, Cleveland

Nagre-recruitPhase 2

Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT05287126

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

University Children's Clinic, Cleveland
Cleveland Clinic, Cleveland

Nagre-recruitPhase 3

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06405087

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland

Nagre-recruitPhase 3

Edad 2 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT05442567

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

Gastro Intestinal Research Institute of Northern Ohio,, Westlake

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 22 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT06810518

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, Cincinnati
Mirador Therapeutics Selected Site, Liberty Township

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522

Evaluation of the SMART IBD App in Pediatric IBD

Cincinnati Children's Hospital Medical Center, Cincinnati

Nagre-recruit

Edad 13 hanggang 17 · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT07195123

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

University of Cincinnati, Cincinnati

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2025 · NCT06750731

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.